Market Overview

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)

121.91 +3.24 (2.73%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/05/18Credit SuisseMaintainsOutperform154.0
4/30/18CitigroupMaintainsBuy173.0
4/27/18Stifel NicolausMaintainsBuy155.0
3/19/18NomuraMaintainsBuy156.0
3/16/18Credit SuisseMaintainsOutperform149.0
2/09/18BMO CapitalMaintainsOutperform180.0
2/09/18Morgan StanleyMaintainsOverweight151.0
2/09/18Leerink SwannMaintainsOutperform153.0
2/09/18Deutsche BankMaintainsBuy161.0
2/09/18CitigroupMaintainsBuy170.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter